about
2-Aminothiazoles as therapeutic leads for prion diseasesElucidating the signal responses of multi-parametric surface plasmon resonance living cell sensing: a comparison between optical modeling and drug-MDCKII cell interaction measurementsChallenges of using in vitro data for modeling P-glycoprotein efflux in the blood-brain barrier.New perspective for the treatment of Alzheimer diseases: liposomal rivastigmine formulations.Why we should be vigilant: drug cytotoxicity observed with in vitro transporter inhibition studies.Application of Caco-2 cell line in herb-drug interaction studies: current approaches and challengesDifferential effect of P-gp and MRP2 on cellular translocation of gemifloxacinCurrent industrial practices of assessing permeability and P-glycoprotein interactionIn vitro models for processes involved in intestinal absorption.Substrate-dependent breast cancer resistance protein (Bcrp1/Abcg2)-mediated interactions: consideration of multiple binding sites in in vitro assay design.Impact of Absorption and Transport on Intelligent Therapeutics and Nano-scale Delivery of Protein Therapeutic Agents.Application of method suitability for drug permeability classification.In vitro and in vivo testing methods for respiratory drug delivery.In vitro cell culture models to study the corneal drug absorption.Experimental models for predicting drug absorption and metabolism.Rhamnose-coated superparamagnetic iron-oxide nanoparticles: an evaluation of their in vitro cytotoxicity, genotoxicity and carcinogenicity.Multi-functional scaling methodology for translational pharmacokinetic and pharmacodynamic applications using integrated microphysiological systems (MPS).Transfected MDCK cell line with enhanced expression of CYP3A4 and P-glycoprotein as a model to study their role in drug transport and metabolism.Macroporous silicon chips for laterally resolved, multi-parametric analysis of epithelial barrier function.Dose-independent pharmacokinetics of a new peroxisome proliferator-activated receptor-γ agonist, KR-62980, in Sprague-Dawley rats and ICR mice.Examining the Uptake of Central Nervous System Drugs and Candidates across the Blood-Brain Barrier.Cells on pores: a simulation-driven analysis of transcellular small molecule transport.Intra-herb pharmacokinetics interaction between quercetin and isorhamentin.Predicting MDCK cell permeation coefficients of organic molecules using membrane-interaction QSAR analysis.Expression Profile of Drug and Nutrient Absorption Related Genes in Madin-Darby Canine Kidney (MDCK) Cells Grown under Differentiation Conditions.Genomic Knockout of Endogenous Canine P-Glycoprotein in Wild-Type, Human P-Glycoprotein and Human BCRP Transfected MDCKII Cell Lines by Zinc Finger Nucleases.Assessment of ABCG2-mediated transport of xenobiotics across the blood-milk barrier of dairy animals using a new MDCKII in vitro model.P-glycoprotein interactions of nefazodone and trazodone in cell culture.Utilizing single- and double-transfected cell models expressing human organic anion transporter 1 and human cytochrome P450 1A2 to investigate the interactions with ingredients of herbal medicines.Fully automatic flow-based device for monitoring of drug permeation across a cell monolayer.
P2860
Q24618566-65D5F001-8EE6-4517-8AB0-8189F96EBE28Q27309042-3A3600CB-6850-4DFD-AAF5-BFD437EB8896Q30651426-1F29A50C-AE06-4D93-B3C5-E8B8759CB60AQ33792474-EC16232A-83DE-4E5A-B2F0-3A479C458DB5Q34148447-F97CB709-BC26-43FE-9B11-6C85F110614EQ35164876-63E98AEE-5305-4770-937A-91463E8C3807Q35374935-6AF41D94-3E33-4778-9828-2DF42138EC4FQ36439145-B4EAC155-8A65-4D4D-AECB-4F1CD8EA6D83Q36909324-B4C61E26-926E-48BF-B4FE-5832350CA1B2Q37187988-6B299637-9A6E-4FCC-9259-B06A8C219576Q37436438-2F51AC26-B139-451E-9D4F-DBFC98FAE131Q37784730-A092647F-8C85-4906-BABC-09592B015B6DQ37822755-2FA4FB95-76D6-494F-9210-A766133CAD43Q37850457-2434690F-A661-4288-8512-C7C7EC32327FQ38107970-B7DA951E-4A48-496C-9863-0F80E281BEA1Q38808707-8A73AA4D-0448-4A31-B7D1-E300718DBCC4Q38925148-63B737FB-69E4-4D31-B32E-F29E2997A555Q39335333-B46A5FA3-4A8F-486D-9AE5-187B7B9BAC3EQ39361091-C110E6D5-6C64-451D-B0B8-FD2F09DDCA0AQ39419374-74C0A7A2-D07B-4C0C-A00A-E3EE489C1147Q39754769-5CA63F51-9291-4358-A4FD-8A96B6901387Q39760846-CD6E39D3-E911-453B-92BF-A35AC35678EFQ39924679-E60C9299-3B69-4C62-AD0C-52004FEEF7F6Q40362059-8AC64E27-479C-406F-9268-1B8F74512893Q41855448-66E47E6B-1A79-49C3-A6D5-0475AA0E1F68Q42470496-D4C2836C-96CF-44F3-9793-F651341D6031Q42711456-E6141566-2306-4E17-97AA-62CF379016EBQ43673448-878BE612-AC69-47D4-BBFA-BEA328BAAA52Q51598656-780C0176-9D99-47D8-80C4-04F01263AE3DQ51626330-14E4C703-D8B3-4014-B059-09B7DE571EC5
P2860
description
2000 nî lūn-bûn
@nan
2000 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Cell cultures as tools in biopharmacy.
@ast
Cell cultures as tools in biopharmacy.
@en
Cell cultures as tools in biopharmacy.
@nl
type
label
Cell cultures as tools in biopharmacy.
@ast
Cell cultures as tools in biopharmacy.
@en
Cell cultures as tools in biopharmacy.
@nl
prefLabel
Cell cultures as tools in biopharmacy.
@ast
Cell cultures as tools in biopharmacy.
@en
Cell cultures as tools in biopharmacy.
@nl
P2093
P1476
Cell cultures as tools in biopharmacy
@en
P2093
Günthert M
Hämmerle S
Wunderli-Allenspach H
P304
P356
10.1016/S0928-0987(00)00164-0
P407
P478
11 Suppl 2
P577
2000-10-01T00:00:00Z